PanGen Biotech Inc.

₩3,890As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:222110Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (13.76%)
Div yield —
ROE 3.76%
Biological Products, Except Diagnostic Substances
Beta (5Y) (0.10)
PE TTM 50.39
TSR TTM (34.07%)
Mkt cap ₩52.57B
ROIC 1.25%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩4,485
15.30%
(44.21%)
Hold 6|0|7|9|11
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
58.95
58.76
60.81
62.69
33.92%
19.54%
13.98%
15.70%
Revenue₩B
2.671
2.660
2.588
2.562
0.11%
1.95%
(2.11%)
(4.84%)
Peers (US$38.76M)
Cap (US$)
PE
44.84M
19.97x
37.84M
—
37.44M
—
39.01M
—
Capital
TTM
5Y
10Y
Leveragex
1.733
0.643
0.638
EBIT/Intx
0.409
0.328
0.324
Own earn%
12.22
(34.41)
(35.08)
Sh yield%
44.98
31.72
33.13
Owners
Insiders/Inst%
2.86
59.73
Short interest%
1.98
SBC / revenue%
3.96
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
25–28
$1 testx
—
Incr. ROIC%
3